Purpose of Study:
A 24-Week Study of the Efficacy and Safety of BLU-5937 in Adults With Refractory Chronic CoughStudy Dates:
November 20, 2022 - January 1, 0001
Type of Study:
Pre-Market
Study Design:
Controlled Design
Study Location:
Nationwide
Lead Institution:
Raleigh-Cary Medical Center
Funding Source:
Bellus Health
Sponsors:
Bellus HealthClinicalTrails.gov Identifier:
NCT05600777
Sponsor:
Bellus Health
Contact Email:
patientmatch@accellacare.com
